Company intelligence / Profile preview

Yunnan Yongzitang Pharmaceutical Co., Ltd.

Zhaotong City, Yunnan Province, Chinapitchbook.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Yunnan Yongzitang Pharmaceutical is a pharmaceutical company specializing in traditional Chinese medicine, with at least one nationally approved product for headache and memory disorders. The company owns several national exclusive TCM patents, reported significant profits as of 2013, and was acquired by Hunan Hansen Pharmaceutical, which now holds an 80% stake. Its lead product is rhizome gastrodiae capsules.

Therapeutic areas: Neurology
Modalities: Herbal medicineSmall molecules
Industry: Biotech

Drug pipeline

11 assets

tianma xingnao jiaonang

Unknown

10 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Yunnan Yongzitang Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Yongzitang Pharmaceutical Co., Ltd..

Explore the full profile